State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $38.3M (CHE)
Key claim: The Department of State obligated $38.3 million to the Global Fund (place of performance Switzerland) to purchase Lenacapavir for PrEP for DOS/GHSD-financed beneficiaries in PEPFAR-supported countries.
Abstract
Department of State obligated $38.3M to THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND), for work in CHE. TO FUND THE PURCHASE OF LENACAPAVIR FOR PREP THROUGH WAMBO.ORG FOR DOS / GHSD-FINANCED BENEFICIARIES IN PEPFAR-SUPPORTED COUNTRIES.
Why this matters
This obligation shows the U.S. using the Global Fund not just for general contributions but as a procurement vehicle for a specific next-generation HIV prevention product (Lenacapavir long-acting PrEP) destined for PEPFAR countries. It signals State/GHSD’s willingness to blend bilateral PEPFAR programming with multilateral procurement to accelerate access to novel HIV prevention tools.